Buprenorphine and naloxone are used to treat adults with opioid addiction.
Dr Reddy’s Labs’ shares gained a little over 3 percent in the opening minutes as investors cheered a regulatory approval to its drug.
The company announced an approval from US FDA and is launching Buprenorphine and Naloxone Sublingual Film, a therapeutic equivalent generic version of Suboxone
Buprenorphine and naloxone are used to treat adults with opioid addiction.
“Buprenorphine helps suppress withdrawal symptoms caused by discontinuation of opioid drugs, and naloxone reverses and blocks the effect of opioids. This combination of medications is used as part of a complete treatment program including prescription monitoring, counseling, and psychosocial support,” the company said in a filing to the exchanges.
The Suboxone brand had US sales of approximately $1.86 billion MAT for the most recent twelve months ending in April 2018 according to IMS Health.
The stock has gained 16 percent in the past one month, while in the past three days, it has surged 6 percent. At 09:29 hrs Dr Reddys Laboratories was quoting at Rs 2,329.05, up Rs 60.65, or 2.67 percent, on the BSE. It touched an intraday high of Rs 2,345.95 and an intraday low of Rs 2,290.00.
Click here for Our Best Services
Free Commodity Tips
Precious Metal Pack is one of our packages for MCX Traders. In this package, we provide Accurate Mcx Tips & Free Commodity Tips i.e. gold tips & silver tips
Equity Tips
Stock Cash Intraday Trading tips is completely based on technical analysis and charting. U can also get stock market live update news, equity intraday tips.
0 comments:
Post a Comment